Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

2009 • 26,132 citations

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

2009 • 9,138 citations

The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions

1998 • 7,417 citations

Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration

2013 • 5,537 citations

Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer

2004 • 3,458 citations

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma

1990 • 2,226 citations

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

2009 • 2,086 citations

Hepatogastroenterology

2012 • 1,583 citations

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

2012 • 1,406 citations

Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2013 • 1,272 citations

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

2005 • 1,212 citations

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07

2007 • 1,011 citations

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

2004 • 994 citations

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

2011 • 717 citations

Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

2011 • 623 citations

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

2011 • 600 citations

Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials

2009 • 596 citations

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

2009 • 451 citations

Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone As Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803

2007 • 435 citations

Prospectively randomized trial of postoperative adjuvant chemotherapy in patients with high-risk colon cancer.

1998 • 416 citations

Validation Study of a Quantitative Multigene Reverse Transcriptase–Polymerase Chain Reaction Assay for Assessment of Recurrence Risk in Patients With Stage II Colon Cancer

2011 • 360 citations

Endpoints in Adjuvant Treatment Trials: A Systematic Review of the Literature in Colon Cancer and Proposed Definitions for Future Trials

2007 • 331 citations

The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients

2010 • 256 citations

Adjuvant Therapy for completely resected Stage II Colon Cancer

2008 • 254 citations

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

2013 • 253 citations

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

2012 • 248 citations

Neurotoxicity From Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: NSABP C-07

2007 • 228 citations

Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer

2010 • 213 citations

Prognostic Significance of Metastatic Lymph Node Ratio in Node-Positive Colon Carcinoma

2007 • 180 citations

Microsatellite Instability and Loss of Heterozygosity at Chromosomal Location 18q: Prospective Evaluation of Biomarkers for Stages II and III Colon Cancer—A Study of CALGB 9581 and 89803

2011 • 179 citations

Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581

2013 • 163 citations

Phase III Study Comparing a Semimonthly With a Monthly Regimen of Fluorouracil and Leucovorin As Adjuvant Treatment for Stage II and III Colon Cancer Patients: Final Results of GERCOR C96.1

2007 • 150 citations

Interventions to Improve Care Related to Colorectal Cancer Among Racial and Ethnic Minorities: A Systematic Review

2012 • 142 citations

Preoperative carcinoembryonic antigen level as an independent prognostic factor in potentially curative colon cancer

2010 • 125 citations

The Cochrane Collaboration:

2002 • 112 citations

Prognostic Value of Perineural Invasion in Patients with Stage II Colorectal Cancer

2010 • 105 citations

Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies

2005 • 97 citations

The prognostic importance of miR-21 in stage II colon cancer: a population-based study

2012 • 95 citations

Prediction of Prognosis Is Not Improved by the Seventh and Latest Edition of the TNM Classification for Colorectal Cancer in a Single-Center Collective

2011 • 93 citations

Localized Colon Cancer, Version 3.2013

2013 • 92 citations

Prognostic Impact of Lymph Node Harvest and Lymph Node Ratio in Patients With Colon Cancer

2012 • 90 citations

Prognostic Impact of Inferior Mesenteric Artery Lymph Node Metastasis in Colorectal Cancer

2010 • 88 citations

Lymph Node Micrometastases and Isolated Tumor Cells Influence Survival in Stage I and II Colon Cancer

2011 • 81 citations

The relation between lymph node status and survival in <scp>S</scp>tage I–<scp>III</scp> colon cancer: results from a prospective nationwide cohort study

2012 • 77 citations

Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy

2011 • 76 citations

Documenting the Natural History of Patients With Resected Stage II Adenocarcinoma of the Colon After Random Assignment to Adjuvant Treatment With Edrecolomab or Observation: Results From CALGB 9581

2011 • 73 citations

Folate Intake,MTHFRPolymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis

2012 • 66 citations

Comparison of Outcomes After Fluorouracil-Based Adjuvant Therapy for Stages II and III Colon Cancer Between 1978 to 1995 and 1996 to 2007: Evidence of Stage Migration From the ACCENT Database

2013 • 65 citations

A study of lymph node ratio as a prognostic marker in colon cancer

2008 • 62 citations

Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival

2011 • 62 citations

Ubiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery

2010 • 60 citations

Cell Cycle Proteins Predict Recurrence in Stage II and III Colon Cancer

2012 • 56 citations

Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients

2012 • 55 citations

Prognostic Impact of Fascin-1 Expression is More Significant in Advanced Colorectal Cancer

2010 • 45 citations

Carcinoma obstruction of the proximal colon cancer and long-term prognosis—obstruction is a predictor of worse outcome in TNM stage II tumor

2010 • 43 citations

The Lymph Node Ratio Is a Powerful Prognostic Factor of Node-Positive Colon Cancers Undergoing Potentially Curative Surgery

2009 • 42 citations

Prognostic value of PRL‐3 overexpression in early stages of colonic cancer

2009 • 42 citations

Prognostic Significance of Thrombocytosis in Node-negative Colon Cancer

2005 • 42 citations

Defining a high-risk subgroup with colon cancer stages I and II for possible adjuvant therapy

2009 • 37 citations

Association of CHFR Promoter Methylation with Disease Recurrence in Locally Advanced Colon Cancer

2011 • 35 citations

Clinical Significance of Lymph Node Micrometastasis in Stage I and II Colon Cancer

2008 • 35 citations

Evaluation of Guanylyl Cyclase C Lymph Node Status for Colon Cancer Staging and Prognosis

2011 • 30 citations

EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review

2014 • 27 citations

Gene‐expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5′fluoruracil‐based adjuvant chemotherapy

2012 • 25 citations

Prognostic Factors Assessed for 15,096 Patients with Colon Cancer in Stages I and II

2012 • 25 citations

Factors predicting oncologic outcomes in patients with fewer than 12 lymph nodes retrieved after curative resection for colon cancer

2011 • 25 citations

Combination of Microsatellite Instability and Lymphocytic Infiltrate as a Prognostic Indicator for Adjuvant Therapy in Colon Cancer

2009 • 16 citations

Carcinoma obstruction of the left colon and long-term prognosis.

2008 • 13 citations

Can the clinical outcome in state II colon carcinomas be predicted by determination of molecular marker expression?

2007 • 11 citations